🧵”The approval process health insurers impose on medical services or drugs is generating a toll that exceeds the purported benefits, according to a physician survey released today by @AmerMedicalAssn and shared in a letter to federal health officials.”
2/ For an infographic of the survey results, please see👇
3/ “While health insurers claim prior authorization requirements are used for cost and quality control, a vast majority of physicians say authorization controls lead to unnecessary waste and avoidable patient harm.”
4/ “‘Health plans continue to inappropriately impose bureaucratic prior authorization policies that conflict with evidence-based clinical practices, waste vital resources, jeopardize quality care, and harm patients,’” said @AmerMedicalAssn President @JackResneckMD.
5/ “‘The byzantine system of authorization controls is rife with opportunities for reform and the AMA continues to work with federal & state officials on legislative solutions to reduce waste, improve efficiency, & protect patients from obstacles to medically necessary care.’”
6/ “According to the AMA survey, more than four in five physicians (8️⃣6️⃣%) reported that prior authorization requirements led to higher overall utilization of health care resources, resulting in unnecessary waste rather than cost-savings.”
7/ “[% physicians who reported resources were diverted due to prior authorization policies]
6️⃣4️⃣% to ineffective initial treatments
6️⃣2️⃣% to additional office visits
4️⃣6️⃣% of physicians reported prior authorization policies led to urgent or emergency care for patients.”
8/ 🔥“The health insurance industry maintains prior authorization criteria reflect evidence-based medicine, but physician experiences call into question the clinical validity of insurer-created criteria that lack transparency.”
9/ ❗️“Only 1️⃣5️⃣% of physicians reported that prior authorization criteria were often or always evidence-based.
❗️Other critical concerns highlighted in the AMA survey include:”
10/ 🔥 “Patient Harm - 3️⃣3️⃣% of physicians reported that prior authorization led to a serious adverse event for a patient in their care, including hospitalization, permanent impairment, or death.”
11/ 🔥”Bad Outcomes - Nearly nine in 10 physicians (8️⃣9️⃣%) reported that prior authorization had a negative impact on patient clinical outcomes.”
12/ 🔥“Delayed Care - More than nine in 10 physicians (9️⃣4️⃣%) reported that prior authorization delayed access to necessary care.”
13/ 🔥”Disrupted Care - Four in five physicians (8️⃣0️⃣%) said patients abandoned treatment due to authorization struggles with health insurers.”
14/ 🔥”Lost Workforce Productivity - More than half of physicians (5️⃣8️⃣%) who cared for patients in the workforce reported that prior authorizations had impeded a patient’s job performance.”
15/ “In addition, a significant majority of physicians (8️⃣8️⃣%) said burdens associated with prior authorization were high or extremely high.”
16/ ❗️“This costly administrative burden pulls resources from direct patient care as medical practices complete an average of 4️⃣5️⃣ prior authorizations per physician, per week, which consume the equivalent of almost 2️⃣ business days (1️⃣4️⃣ hours) of physician and staff time.”
17/ “To keep up with the administrative burden, nearly two in five physicians (3️⃣5️⃣%) employed staff members to work exclusively on tasks associated with prior authorization.”
18/ “The AMA survey results illustrate a critical need to streamline or eliminate low-value prior authorization requirements to minimize waste, delays, and disruptions in care delivery.”
19/ “The AMA has taken a leading role in advocating for prior authorization reforms and today submitted comments to @CMSGov largely supporting the agency’s proposals to improve prior authorization.”
20/ “These [CMS] proposals align with the AMA’s 2017 Prior Authorization and Utilization Management Reform Principles.”
Read Principles here developed by a multi-stakeholder group including patients, physicians, & others 👉 tinyurl.com/2p9kmuku
21/ These CMS proposals also align with “2018 Consensus Statement on Improving the Prior Authorization Process and will significantly improve prior authorization across a number of federal and state insurance programs.”
22/ "’The AMA greatly appreciates Administrator Brooks-LaSure’s reform proposal and its focus on the role of payer decision-making and electronic information exchange in the prior authorization process,’” said @JackResneckMD.
23/ “‘CMS has proposed two sets of rules on prior authorization, and as in comments on the initial rule, the AMA continues to applaud the administrator for acknowledging patient and physician concerns in both sets of proposed rules.’”
24/ “The AMA also provided the administrator with several recommendations to strengthen CMS’ proposals, particularly around the rule’s scope, payer transparency, and processing time requirements.”
25/ “The AMA continues to work on every front to streamline prior authorization.”
Read reform initiatives and resources, practice resources, research and reports from AMA 👉 ama-assn.org/practice-manag…
26/ Through the “Recovery Plan for America’s Physicians the AMA is working to right-size prior authorization programs so that physicians can focus on patients rather than paperwork.”
27/ “Patients, physicians, and employers can learn more about reform efforts and share personal experiences with prior authorization at FixPriorAuth.org.”
2/ “The 340B program was established in response to concerns among safety-net providers regarding the Medicaid Drug Rebate Program, which was enacted in 1990 and required manufacturers to offer their lowest prices to the Medicaid program.”
3/ “An inadvertent effect of [Medicaid Drug Rebate] policy was that safety-net providers lost access to the discounts they had previously received from drug manufacturers. The 340B program was intended to restore discounts to providers caring for low-income and uninsured people.”
“The AMA already has serious concerns about #PBM business practices that can have a detrimental impact on patients’ access to and cost of prescription drugs.”
“Hospitals and doctors strongly believe that no patient should fear receiving a surprise medical bill and that patients should be kept out of the middle of any billing disputes between providers and commercial health insurance companies.”
continued 👇
3/“The AHA & AMA fully support the lawsuit just filed in the United States District Court for the Eastern District of Texas which challenges the government’s August 2022 final rule (tinyurl.com/ycypc2fa) regarding the No Surprises Act’s independent dispute resolution process.”
🧵👏👏 TY @RepBera @RepLarryBucshon for introducing HR 8800, the “Supporting Medicare Providers Act of 2022.”
This would give critical support to physicians who, w/release of the proposed rule for the 2023 Medicare Physician Fee Schedule, again face payment cuts.
2/ Read: Across-the-board Medicare physician pay cuts are wrong way forward
3/ The bipartisan legislation would provide relief from the scheduled 4.42% Medicare conversion factor payment cut and offer stability as the @AmerMedicalAssn works to improve the #Medicare payment system.
“…PBMs make up an oligopoly of rich, vertically integrated conglomerates that routinely prey on health care practices, providers, and their patients.”
2/ “PBMs have done this by overwhelmingly abusing their responsibility to protect Americans from this country’s drug pricing crisis, instead exploiting the opacity throughout the nation’s drug supply chain to enrich themselves.”
3/ “[The report] explores how the recent levels of consolidation among PBMs and health insurers is adversely impacting #cancer care, fueling drug costs, all while allowing for massive profits for #PBMs and health insurance companies.”